The company offers molecular biology instrumentation and composite liquid cell platform technology for various applications, such as sample extraction and preparation, library preparation for next-gen sequencing, PCR genotyping, qPCR, digital PCR, and proteomic assays. Their Composite Liquid Cells (CLCs) provide a new method of confining, transporting, combining, processing, and analyzing biological reactions. BD-GenCell Biosystems, which was acquired by BD in 2014, provides robust, high-performance systems for faster and lower-cost analysis. The company collaborates with established biotech companies and universities to develop innovative technologies.